Quarterly report · Q2
6095.TEDINET S100QPSY
Period2022-10-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥8.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥717m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥867m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥735m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥890m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥735m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥890m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥380m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥812m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥599m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥391m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥618m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥14.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥9.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥122m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥853m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥538m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.8bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥423m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥78m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.2bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥17.42 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.62 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.74 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.57 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.05 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.78 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.26 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 57.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥657m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥5.7bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥5.7bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥2m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥243m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥3m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥40m |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.2bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥300,000 |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥94m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-03-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-03-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥645m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥3.2bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥3.2bn |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥2m |
| jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥1.3bn |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥202m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥199m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥30m |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥1.0bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥1.0bn |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥137m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥4.4bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥4.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥7m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 506
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income | CurrentYTDDuration | 389997000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 595015000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 379764000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 18977000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 10233000 | JPY |
| Income before income taxes | Prior1YTDDuration | 889882000 | JPY |
| Income before income taxes | CurrentYTDDuration | 735082000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 64679000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 69493000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 18414000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 283721000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -19912000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -85457000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | － | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -766000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | Prior1YTDDuration | -3223000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYTDDuration | -14701000 | JPY |
| Increase decrease in provision for point card certificates ope cf | Prior1YTDDuration | 1321000 | JPY |
| Increase decrease in provision for point card certificates ope cf | CurrentYTDDuration | -8183000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -696000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -699000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 452000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 6845000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -22689000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -26219000 | JPY |
| Increase decrease in trade receivables and contract assets ope cf | Prior1YTDDuration | -192038000 | JPY |
| Increase decrease in trade receivables and contract assets ope cf | CurrentYTDDuration | -402453000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 58340000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 5548000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 5297000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 20706000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | 96706000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -18077000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | -41826000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -142559000 | JPY |
| Other net ope cf | Prior1YTDDuration | 20512000 | JPY |
| Other net ope cf | CurrentYTDDuration | -74602000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 875220000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 347677000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 696000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 699000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -445000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -7117000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -337781000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -218948000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 537690000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 122311000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -24768000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -3840000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -54349000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |